Dr Bharat Mishra, Dr Chetna Arora


Keloids and hypertrophic scars are benign dermal bro-proliferative characterized by an uncontrolled proliferation of brous tissue. They are more
common in dark skinned people and certain areas are more prone for pathological scarring. This study was conducted to nd the epidemiology of
keloids and hypertrophic scarring in outdoor patients of Plastic Surgery department of a tertiary care teaching hospital. This METHODS study
was conducted in the a tertiary teaching hospital of Northern India, over a period of 18 months. The prospective study included all patients
presenting to the plastic surgery OPD with keloids and hypertrophic scars. RESULTS One hundred seven patients (39 females and 68 males) with
mean age 35.68 year were included. Pre sternum was the most common site, followed by torso, back and extremities. The most common cause was
trauma (including minor trauma) which was found in 29 patients followed by post infective origin in 22 patients. Pain was not a major complaint
most of the patients complained of pruritis. CONCLUSION This, an epidemiological study, was carried out in a tertiary hospital of northern
India. The keloids and hypertrophic scars are more common in young males and most common cause being trauma and most commonly affected
site is Pre-sternum. Itching is a common complaint though localized pain was complained by a few patients only.

Full Text:



Atiyeh, B., Costagliola, M. and Hayek, S. (2005). Keloid or Hypertrophic Scar. Annals of Plastic Surgery, 54(6), 676-680.

AlibertJLM, Quelques recherché sur la cheloide, Men Soc Medicale d’ Emulation 1917;8:744-52

Ogawa, R., Okai, K., Tokumura, F., Mori, K., Ohmori, Y., Huang, C., Hyakusoku, H. and Akaishi, S. (2012). The relationship between skin stretching/contraction and pathologic scarring: The important role of mechanical forces in keloid generation. Wound Repair and Regeneration, 20(2), 149-157.

Alster, T. and Tanzi, E. (2003). Hypertrophic Scars and Keloids. American Journal of Clinical Dermatology, 4(4), 235-243.

Bodokh I, Brun P. Treatment of keloid with intralesional bleomycin. Ann Dermatol Venereol1996;123:791-4

Castagnoli, C., Peruccio, D., Stella, M., Magliacani, G., Mazzola, G., Amoroso, A. and Richiardi, P. (1990). The HLA-DRβ16 allogenotype constitutes a risk factor for hypertrophic scarring. Human Immunology, 29(3), 229-232.

Alster, T. and Tanzi, E. (2003). Hypertrophic Scars and Keloids. American Journal of Clinical Dermatology, 4(4), 235-243.

Gangemi, E., Gregori, D., Berchialla, P., Zingarelli, E., Cairo, M., Bollero, D., Ganem, J., Capocelli, R., Cuccuru, F., Cassano, P., Risso, D. and Stella, M. (2008). Epidemiology and Risk Factors for Pathologic Scarring After Burn Wounds. Archives of Facial Plastic Surgery, 10(2).


  • There are currently no refbacks.